Bal Pharma Ltd (BALP)

Currency in INR
77.94
-0.16(-0.20%)
Real-time Data·
BALP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
76.0179.00
52 wk Range
60.00111.18
Key Statistics
Bid/Ask
77.01 / 77.89
Prev. Close
78.1
Open
78.1
Day's Range
76.01-79
52 wk Range
60-111.18
Volume
1.54K
Average Volume (3m)
11.68K
1-Year Change
-30.7561%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BALP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Employees
986
Market
India

Compare BALP to Peers and Sector

Metrics to compare
BALP
Peers
Sector
Relationship
P/E Ratio
15.7x20.6x−0.4x
PEG Ratio
−8.400.010.00
Price/Book
1.6x1.0x2.6x
Price / LTM Sales
0.4x1.3x3.2x
Upside (Analyst Target)
-25.2%46.7%
Fair Value Upside
Unlock7.4%7.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.82%
Dividend Yield
1.53%
Industry Median 0.76%
Annualised payout
1.20
Paid annually
5-Years Growth
+3.71%
Growth Streak

Earnings

Latest Release
11/02/2026
EPS / Forecast
1.12 / --
Revenue / Forecast
876.9M / --
EPS Revisions
Last 90 days

People Also Watch

158.50
NACP
0.00%
245.35
VINE
0.00%

FAQ

What Is the Bal Pharma Ltd (NSE: BALP) Share Price Today?

The Bal Pharma Ltd stock price today is 77.94 INR.

What Stock Exchange Does Bal Pharma Ltd (BALP) Trade On?

Bal Pharma Ltd is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Bal Pharma Ltd?

The stock symbol (also called a 'ticker') for Bal Pharma Ltd is "BALP."

Does Bal Pharma Ltd Pay Dividends? What’s The Current BALP Dividend Yield?

Yes, BALP Pays Dividends to its Shareholders. The current Bal Pharma Ltd dividend yield is 1.53%.

What Is the Current Bal Pharma Ltd Market Capitalisation?

As of today, Bal Pharma Ltd (NSE: BALP) market cap is 1.21B INR.

What Is Bal Pharma Ltd's (BALP) Earnings Per Share (TTM)?

The Bal Pharma Ltd EPS is currently 4.82 (Trailing Twelve Months).

Is BALP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bal Pharma Ltd moving averages and other technical indicators, the daily buy/sell signal for BALP stock is Strong Buy.

How Many Times Has Bal Pharma Ltd Stock Split?

Bal Pharma Ltd has split 0 times. (See the BALP stock split history page for full effective split date and price information.)

How Many Employees Does Bal Pharma Ltd Have?

Bal Pharma Ltd has 986 employees, based on their latest Companies House report.

What is the current trading status of Bal Pharma Ltd (NSE: BALP)?

As of 24/04/2026, Bal Pharma Ltd (BALP) is trading at a share price of 77.94 INR, with a previous close of 78.10 INR. The stock has fluctuated within a day range of 76.01 INR to 79.00 INR, while its 52-week range spans from 60.00 INR to 111.18 INR.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.